{"id":3202,"date":"2019-09-09T13:49:22","date_gmt":"2019-09-09T11:49:22","guid":{"rendered":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?p=3202"},"modified":"2019-09-09T13:49:22","modified_gmt":"2019-09-09T11:49:22","slug":"nouvelle-publication-acceptee-2","status":"publish","type":"post","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/","title":{"rendered":"Nouvelle publication accept\u00e9e\u00a0!"},"content":{"rendered":"<p>Les travaux de Clovis Lusivika-Nzinga, \u00e9tudiant en th\u00e8se sous la direction du Pr Fabrice Carrat au sein de l\u2019unit\u00e9 INSERM U1136 \u00e0 Paris, portant sur l\u2019effet dynamique des traitements antiviraux \u00e0 action directe sur le risque de Carcinome H\u00e9patoCellulaire (CHC) chez les patients atteints d\u2019une h\u00e9patite C chronique et cirrhotique ont \u00e9t\u00e9 accept\u00e9s pour publication dans la revue scientifique <i>Journal of Viral Hepatitis<\/i>. Ce travail montre la diminution progressive du risque de survenue de carcinome h\u00e9ptocellulaire avec le temps depuis l\u2019obtention d\u2019une r\u00e9ponse virologique soutenue, aussi bien chez les patients pr\u00e9sentant une cirrhose que chez les patients sans cirrhose au moment du traitement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les travaux de Clovis Lusivika-Nzinga, \u00e9tudiant en th\u00e8se sous la direction du Pr Fabrice Carrat au sein de l\u2019unit\u00e9 INSERM U1136 \u00e0 Paris, portant sur l\u2019effet dynamique des traitements antiviraux \u00e0 action directe sur le risque de Carcinome H\u00e9patoCellulaire (CHC) chez les patients atteints d\u2019une h\u00e9patite C chronique et cirrhotique ont \u00e9t\u00e9 accept\u00e9s pour publication [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-3202","post","type-post","status-publish","format-standard","hentry","category-non-classe"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER\" \/>\n<meta property=\"og:description\" content=\"Les travaux de Clovis Lusivika-Nzinga, \u00e9tudiant en th\u00e8se sous la direction du Pr Fabrice Carrat au sein de l\u2019unit\u00e9 INSERM U1136 \u00e0 Paris, portant sur l\u2019effet dynamique des traitements antiviraux \u00e0 action directe sur le risque de Carcinome H\u00e9patoCellulaire (CHC) chez les patients atteints d\u2019une h\u00e9patite C chronique et cirrhotique ont \u00e9t\u00e9 accept\u00e9s pour publication [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\" \/>\n<meta property=\"og:site_name\" content=\"ANRS CO22 HEPATHER\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-09T11:49:22+00:00\" \/>\n<meta name=\"author\" content=\"C\u00e9line Dorival Mouly\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"C\u00e9line Dorival Mouly\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\"},\"author\":{\"name\":\"C\u00e9line Dorival Mouly\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/553d43120dece2a0d2bbaa4e4cfec91d\"},\"headline\":\"Nouvelle publication accept\u00e9e\u00a0!\",\"datePublished\":\"2019-09-09T11:49:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\"},\"wordCount\":117,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\",\"name\":\"Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER\",\"isPartOf\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\"},\"datePublished\":\"2019-09-09T11:49:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelle publication accept\u00e9e\u00a0!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"name\":\"ANRS CO22 HEPATHER\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\",\"name\":\"IPLESP UMRS 1136\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"width\":464,\"height\":175,\"caption\":\"IPLESP UMRS 1136\"},\"image\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/553d43120dece2a0d2bbaa4e4cfec91d\",\"name\":\"C\u00e9line Dorival Mouly\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g\",\"caption\":\"C\u00e9line Dorival Mouly\"},\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/author\/cdorival\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER","og_description":"Les travaux de Clovis Lusivika-Nzinga, \u00e9tudiant en th\u00e8se sous la direction du Pr Fabrice Carrat au sein de l\u2019unit\u00e9 INSERM U1136 \u00e0 Paris, portant sur l\u2019effet dynamique des traitements antiviraux \u00e0 action directe sur le risque de Carcinome H\u00e9patoCellulaire (CHC) chez les patients atteints d\u2019une h\u00e9patite C chronique et cirrhotique ont \u00e9t\u00e9 accept\u00e9s pour publication [&hellip;]","og_url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/","og_site_name":"ANRS CO22 HEPATHER","article_published_time":"2019-09-09T11:49:22+00:00","author":"C\u00e9line Dorival Mouly","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"C\u00e9line Dorival Mouly","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#article","isPartOf":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/"},"author":{"name":"C\u00e9line Dorival Mouly","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/553d43120dece2a0d2bbaa4e4cfec91d"},"headline":"Nouvelle publication accept\u00e9e\u00a0!","datePublished":"2019-09-09T11:49:22+00:00","mainEntityOfPage":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/"},"wordCount":117,"commentCount":0,"publisher":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization"},"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/","name":"Nouvelle publication accept\u00e9e\u00a0! - ANRS CO22 HEPATHER","isPartOf":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website"},"datePublished":"2019-09-09T11:49:22+00:00","breadcrumb":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/nouvelle-publication-acceptee-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/"},{"@type":"ListItem","position":2,"name":"Nouvelle publication accept\u00e9e\u00a0!"}]},{"@type":"WebSite","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","name":"ANRS CO22 HEPATHER","description":"","publisher":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization","name":"IPLESP UMRS 1136","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","contentUrl":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","width":464,"height":175,"caption":"IPLESP UMRS 1136"},"image":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/553d43120dece2a0d2bbaa4e4cfec91d","name":"C\u00e9line Dorival Mouly","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b23138c7c9987934de7cd81547177ffda26257cebf6ba0ec217a27401b82bfc1?s=96&d=mm&r=g","caption":"C\u00e9line Dorival Mouly"},"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/author\/cdorival\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paQKc4-PE","jetpack-related-posts":[{"id":3290,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/4-travaux-publies-en-2019-dans-le-domaine-de-lhepatite-virale-c\/","url_meta":{"origin":3202,"position":0},"title":"4 travaux publi\u00e9s en 2019 dans le domaine de l\u2019h\u00e9patite virale C","author":"admin_fchau","date":"3 novembre 2019","format":false,"excerpt":"4 travaux publi\u00e9s en 2019 dans le domaine de l\u2019h\u00e9patite virale C \u00a0 A notre connaissance, l'\u00e9tude de cohorte ANRS CO22 Hepather a \u00e9t\u00e9 la premi\u00e8re \u00e9tude longitudinale prospective \u00e0 explorer les r\u00e9sultats cliniques associ\u00e9s au traitement par anti-viraux directs (AVD) chez les patients atteints d'h\u00e9patite C chronique, en comparant\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3303,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/deja-11-travaux-publies-en-2021\/","url_meta":{"origin":3202,"position":1},"title":"D\u00e9j\u00e0 11 travaux publi\u00e9s en 2021\u00a0!","author":"admin_fchau","date":"23 novembre 2021","format":false,"excerpt":"D\u00e9j\u00e0 11 travaux publi\u00e9s en 2021\u00a0! H\u00e9patite virale C\u00a0: Au cours des 4 derni\u00e8res ann\u00e9es, plusieurs \u00e9tudes ont port\u00e9 sur l'identification ou la pr\u00e9diction du carcinome h\u00e9patocellulaire chez les patients infect\u00e9s par l'h\u00e9patite C, avant ou apr\u00e8s la gu\u00e9rison virologique. La biobanque de cohorte a, entre autre, \u00e9t\u00e9 utilis\u00e9e pour\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3372,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/2022-15-travaux-publies-a-partir-des-donnees-de-la-cohorte-hepather\/","url_meta":{"origin":3202,"position":2},"title":"2022. 15 travaux publi\u00e9s \u00e0 partir des donn\u00e9es de la cohorte HEPATHER !","author":"admin_fchau","date":"17 d\u00e9cembre 2022","format":false,"excerpt":"Ces \u00e9tudes apportent des avanc\u00e9es importantes dans la compr\u00e9hension des h\u00e9patites virales B et C et de leurs complications, notamment en mati\u00e8re de d\u00e9pistage pr\u00e9coce, de facteurs de risque et de strat\u00e9gies pr\u00e9ventives.Plusieurs \u00e9tudes r\u00e9alis\u00e9es par l'\u00e9quipe de sciences sociales du SESSTIM (Inserm, Universit\u00e9 Aix Marseille et IRD) ont port\u00e9\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3393,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/2024-une-annee-de-preparation-et-de-transition-3-publications-par-lequipe-du-sesstim\/","url_meta":{"origin":3202,"position":3},"title":"2024 &#8211; une ann\u00e9e de pr\u00e9paration et de transition. 3 publications par l&rsquo;\u00e9quipe du SESSTIM.","author":"admin_fchau","date":"17 mars 2025","format":false,"excerpt":"L'ann\u00e9e 2024 a \u00e9t\u00e9 marqu\u00e9e par la pr\u00e9paration de la suite de la cohorte HEPATHER dont la date de fin \u00e9tait programm\u00e9e au 31 d\u00e9cembre 2024.Hepat-B proposera de prolonger le suivi des patients atteints d'h\u00e9patite B inclus dans Hepather jusqu'en 2029, avec la r\u00e9alisation de nouvelles collections biologiques. Cette cohorte\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":479,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-c\/","url_meta":{"origin":3202,"position":4},"title":"Pas de diff\u00e9rence dans la vitesse de progression de la r\u00e9cidive de carcinome h\u00e9patocellulaire en lien avec le traitement par antiviraux directs.","author":"admin_ft","date":"8 janvier 2019","format":false,"excerpt":"Il est aujourd\u2019hui admis que le traitement de l\u2019h\u00e9patite C par antiviraux directs n\u2019augmente pas le risque de r\u00e9cidive de carcinome h\u00e9patocellulaire chez les patients ayant re\u00e7u un traitement curatif pour ce cancer. La question demeurait n\u00e9anmoins d\u2019une progression plus rapide de cette r\u00e9cidive lorsqu\u2019elle survient chez les patients recevant\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3206,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/7-travaux-issus-de-la-cohorte-seront-presentes-au-congres-americain-de-lamerican-association-for-the-study-of-liver-diseases-aasld-en-novembre-2019\/","url_meta":{"origin":3202,"position":5},"title":"7 travaux issus de la cohorte seront pr\u00e9sent\u00e9s au congr\u00e8s am\u00e9ricain de l\u2019American Association for the Study of Liver Diseases (AASLD) en novembre 2019\u00a0!","author":"C\u00e9line Dorival Mouly","date":"9 septembre 2019","format":false,"excerpt":"Diff\u00e9rentes \u00e9tudes issues des donn\u00e9es de la cohorte HEPATHER seront pr\u00e9sent\u00e9s au congr\u00e8s de l\u2019AASLD qui se d\u00e9roule du 8 au 12 novembre 2019 \u00e0 Boston. \u00a0 1 travail sera pr\u00e9sent\u00e9 \u00e0 l\u2019oral \u00a0: Lors de la session parall\u00e8le 28 le lundi 11 novembre \u00e0 11h30 (Ballroom A) L\u2019impact sur\u2026","rel":"","context":"Dans &quot;Non class\u00e9&quot;","block_context":{"text":"Non class\u00e9","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/non-classe\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/3202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/comments?post=3202"}],"version-history":[{"count":1,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/3202\/revisions"}],"predecessor-version":[{"id":3203,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/3202\/revisions\/3203"}],"wp:attachment":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/media?parent=3202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/categories?post=3202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/tags?post=3202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}